Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue.
about
Oral Mucositis Induced By Anticancer TherapiesOral complications in hematopoietic stem cell recipients: the role of inflammationEfficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapyRole of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation.Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.Oral mucositis induced by anticancer treatments: physiopathology and treatments.Oral mucositis: time for more studies.Oral manifestations in transplant patientsThe influence of dental care associated with laser therapy on oral mucositis during allogeneic hematopoietic cell transplant: retrospective study.Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation.Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 TrialInfluence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT).Nutrition issues in hematopoietic stem cell transplantation: state of the art.CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantationA scoring system for the assessment of oral mucositis in daily nursing practice.The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review.Oral health as a predictive factor for oral mucositisPain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies.Keratinocyte growth factor.Mucositis in malignant hematology.Challenges and outcomes of a randomized study of early nutrition support during autologous stem-cell transplantation.Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy.Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT.Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa.Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients.Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia.Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy.Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation.The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients.Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of aAn oral care self-management support protocol (OrCaSS) to reduce oral mucositis in hospitalized patients with acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation: a randomized controlled pilot study.Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing camelia sinensis leaf extract.Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen.A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: a retrospective study.BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.
P2860
Q26777493-579950D7-A3AC-435A-96E7-77AEFE6DAEEBQ27027650-19B0A481-0174-4846-8020-94FB1E260BCAQ30639590-6AC5BB53-4BDF-48F2-BDE8-A810BCF429EAQ33260759-180C43FE-C792-445C-9AAA-C22DF3C4DEAAQ34037221-BBF87DE7-39F4-457F-BA40-8C1A2C759E65Q34612183-4740F48A-A6F7-4206-9450-C1E675D5F7D3Q34692009-145CBD26-6D35-4D21-9E05-24789B87F1D4Q35166803-EC982429-1289-4021-98A0-B11881783FFBQ35173183-9A8BB177-3D5F-4457-AE50-89966D991A4FQ35608915-85C918C0-45A3-48AA-8418-956840A1E6EDQ35892649-8B4D5FA1-1DDA-42BE-BB55-FA4DF55CF267Q36138187-361DD83F-52F7-4FC3-AE0D-153AF9AD7843Q36237979-908E1283-4B8A-440E-ABA3-4E53E03CAD01Q36250652-19F9C3C1-9CF6-42CF-9423-85305E9C6EBCQ36278418-39345592-3FC8-4956-95C1-7EEE52D5D64AQ36403184-B03BCE14-0310-4246-9A99-9638C133532EQ36553808-6F600E52-4023-491B-B161-B635614EA179Q36687474-12E12D3C-89DE-4404-A595-F6B5D640A20AQ36906825-83675298-11D8-47B9-BF7D-88B551E9CE82Q37075870-9B1DDBAA-26C4-40EE-9018-B2F0EDC8B710Q37489900-3133B469-C4C0-4D9B-A5BE-4B41EA21B435Q37810071-77F16703-265B-4260-BA57-BAAC2BA06C51Q38928899-EAB03D78-5CE9-42F9-BA05-E67B2FCC9D10Q39287519-591B125D-4A2D-4F56-BB46-B0D68707C5E4Q39339322-35008E27-6A7A-4A61-BCC7-11EC375F2ED7Q39374803-7B6DD9D5-D346-470F-8712-D4F94CFA1640Q40201079-3B634194-CB2F-4427-8E9B-65D76675DC3FQ40214682-893F898B-4DA9-4FE9-A05D-11734D950100Q40273088-124B0B93-827D-403D-BB1A-D1DF9C670826Q40331396-C0BC4801-BE81-4C8E-BED2-AEE312F8A43EQ40333673-71D54B19-B521-4A31-B496-C40A2BE098D2Q40410198-A29B3BA4-6313-4AF5-8EB2-27C658F5E901Q40415634-416D1DC3-3695-41AD-8869-32F3539CA1D3Q40581432-CB55C208-7B00-4559-B20A-7259C21C464FQ40719842-713101FE-097A-416F-AB8C-1055140E99C6Q43080886-28D8F130-B0FA-43B9-8AEF-D80068A2DA23Q43685983-DD833965-7899-4BAD-8710-56D74BFF3162Q44198863-6AC13CFA-0743-4BEB-9CD2-DD1D9179CE32Q44523022-E8FD4ACB-BBB1-4598-8B21-3A6BABC7D419Q44548374-964A04FB-C78E-4291-8777-2648C622E177
P2860
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@ast
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@en
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@nl
type
label
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@ast
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@en
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@nl
prefLabel
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@ast
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@en
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@nl
P2093
P2860
P1476
Prospective evaluation of oral ...... aemopoietic progenitor rescue.
@en
P2093
Morgenstern GR
Scarffe JH
Swindell R
Wardley AM
P2860
P304
P356
10.1046/J.1365-2141.2000.02202.X
P407
P577
2000-08-01T00:00:00Z